Skip to main content

Cancer Metastasis

Study Provides New Insights into the Genetic Complexity of Cancer Metastasis



When cancer spreads from a primary tumor to new sites throughout the body, it undergoes changes that increase its genetic complexity.

A new study from researchers at Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center (MSK) provides fresh insights about how cancers evolve when they metastasize - insights that could aid in developing strategies to improve the effectiveness of treatment.

The team - led by collaborators Dr. Luc Morris, a surgeon and cancer genetics research lab director at MSK, Dr. Xi Kathy Zhou, a professor of research in population health sciences at Weill Cornell Medicine, and Dr. Chaitanya Bandlamudi, a cancer genomics researcher at MSK - examined the genomic profiles of more than 3,700 patients across 24 cancer types who had multiple tumor sites biopsied over time.

The samples were profiled using MSK's proprietary tumor sequencing test. This allowed the research team to compare the genetic profiles of an initial tumor and metastatic site from the same patient.
Metastatic Tumors Harbor More Copy-Number Alterations

The team’s findings, which were published June 2 in Nature Genetics, showed that tumors evolve over time, and that metastases tend to accumulate more copy-number alterations (CNAs) than mutations. This led the researchers to wonder why CNAs, but not mutations, were so commonly emerging when tumors metastasized.

Mutations are like small typos in the genetic code that can affect how a gene functions, leading to the production of abnormal proteins or the alteration of gene expression. CNAs, on the other hand, are larger scale duplications or deletions of genetic material.

One extreme form of CNA - genome doubling - turned out to be important during the process of metastasis.

“We found that whole-genome duplication - which is the doubling of the entire set of chromosomes in a cancer cell - was the most common genetic event during metastasis, occurring in nearly one-third of patients," explained study first author Dr. Karena Zhao, who conducted research at MSK while attending medical school at Weill Cornell Medical College.

As cancer cells divide and make mistakes in replicating their DNA, mutations accumulate. Some mutations help the cells grow faster, while other mutations can affect essential genes and be harmful to the cell.

“Genome doubling allows cancer cells to hedge their bets, creating additional copies of genes, so that one copy can be mutated or deleted, while the other copy survives intact,” Dr. Zhou added. “This enhances the tumor cell’s ability to adapt, survive, and resist treatments.”

Understanding Genomic Differences Between Primary and Metastatic Tumors Is Critical


Unlike CNAs, more mutations can actually make tumors more visible to the immune system. That’s because the changes to their genetic sequences can make them produce abnormal proteins, which are then treated like a foreign threat by the immune system. The team found that CNAs made tumors resistant, while mutations made tumors more susceptible to immunotherapy.

“In the end, our study found that during metastasis, cancer cells tend to evolve by maximizing CNAs, while not generating too many mutations that could potentially stimulate an immune response,” Dr. Bandlamudi said.

Together, the findings suggest that newer strategies, such as therapies to target genetic instability in these highly altered cells or to alter the tumor microenvironment, could be critical for creating lasting responses in metastatic cancer, the researchers said.

“Understanding these key genomic differences between primary and metastatic tumors is vital for clinical care, as biomarkers like CNAs and tumor mutational burden are increasingly used by clinicians to inform decision-making, especially around the use of immunotherapy drugs,” Dr. Morris said.

cancer metastasis, tumor progression, metastatic cascade, epithelial-mesenchymal transition, circulating tumor cells, invasion and migration, angiogenesis, lymphatic spread, bone metastasis, brain metastasis, lung metastasis, liver metastasis, metastasis suppression, cancer microenvironment, exosomes in cancer, cancer biomarkers, cancer stem cells, metastatic niche, immunotherapy in metastasis, targeted therapy

#CancerMetastasis, #TumorProgression, #MetastaticCascade, #EMT, #CTCs, #InvasionAndMigration, #Angiogenesis, #LymphaticSpread, #BoneMetastasis, #BrainMetastasis, #LungMetastasis, #LiverMetastasis, #MetastasisSuppression, #TumorMicroenvironment, #CancerExosomes, #CancerBiomarkers, #CancerStemCells, #MetastaticNiche, #MetastasisResearch, #TargetedTherapy

International Conference on Genetics and Genomics of Diseases

Visit: genetics-conferences.healthcarek.com

Award Nomination: genetics-conferences.healthcarek.com/award-nomination/?ecategory=Awards&rcategory=Awardee

Award registration: genetics-conferences.healthcarek.com/award-registration/

For Enquiries: contact@healthcarek.com

Get Connected Here
---------------------------------
---------------------------------
in.pinterest.com/Dorita0211
twitter.com/Dorita_02_11_
facebook.com/profile.php?id=61555903296992
instagram.com/p/C4ukfcOsK36
genetics-awards.blogspot.com/
youtube.com/@GeneticsHealthcare
linkedin.com/in/genetics-research-160337363/

Comments

Post a Comment

Popular posts from this blog

Genetics role in ovarian cancer

The Medical Minute: Genetics play big role in ovarian cancer In 2024, about 19,680 women in the United States will receive a new diagnosis of ovarian cancer and 12,740 women will die from the disease, said Dr. Shaina Bruce , a gynecologic oncologist at Penn State Cancer Institute . The median age of all patients who develop ovarian cancer is 63. Historically, women at increased risk for ovarian cancer are recommended to have their fallopian tubes and ovaries removed when they have completed having children. Taking that step to protect themselves comes at a heavy price ― surgical menopause. But Bruce said medical science is catching up with ovarian cancer. Studies could lead to new methods for preventative care and the surgery needed to lower risk may be easier than it once was. Below, during Gynecologic Cancer Awareness Month, Bruce discusses the disease and why acting to reduce your risk is worth it. What’s the connection between heredity and ovarian cancer? About 25% of all cases of ...
Post a Comment
Read more

Multifactorial Genetic Conditions

Multifactorial Genetic Conditions Multifactorial genetic conditions are disorders caused by the combined effects of multiple genes and environmental factors , rather than a single gene mutation . These conditions do not follow classic Mendelian inheritance patterns and instead result from complex gene–environment interactions . Factors such as lifestyle, nutrition, infections, stress, and exposure to toxins can significantly influence disease onset and severity in genetically susceptible individuals. Common examples include diabetes, cardiovascular diseases , neural tube defects, asthma, and many neuropsychiatric disorders. Understanding multifactorial inheritance is essential for risk prediction, preventive medicine, and personalized healthcare strategies. Multifactorial inheritance, polygenic traits, gene–environment interaction, complex diseases, genetic susceptibility, environmental risk factors, non-Mendelian inheritance, disease predisposition, polygenic risk score, precision ...
Post a Comment
Read more

X chromosome

Gene on the X chromosome may help explain high multiple sclerosis rates in women Brain inflammation may be fueled by a gene on the X chromosome, a new study in mice suggests. And in female mice, who carry two X chromosomes, a diabetes drug called metformin may work to counteract that inflammation. If these findings bear out in later studies, they could help to unravel the long-standing mystery of why women, who have two copies of this inflammation-driving gene, are more prone to certain autoimmune diseases, particularly after menopause. A disparity between the sexes Our bodies are patrolled by immune cells that provide protection against bacteria and viruses, but sometimes, these defenses turn on us. In the autoimmune disorder multiple sclerosis (MS), for instance, the immune system attacks myelin, the fatty insulation surrounding the nerve fibers in the brain and spinal cord. This leads to symptoms such as muscle weakness and difficulty walking, as well issues with memory and thinking...
Post a Comment
Read more